Gemfibrozil reduces plasma prothrombin fragment Fl+2 concentration, a marker of coagulability, in patients with coronary heart disease - Wilkes, HC; Meade, TW; Barzegar, S; Foley, AJ; Hughes, LO; Bauer, KA; Rosenberg, RD; Miller, GJ (Thromb Haemost, 1992)